Skip to content

Clinical trials

Phase 2 Pathologic Processes trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 2 Country / region: Norway Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
KAI Pharmaceuticals1
University Hospital, Akershus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes2
Brain Diseases1
Cardiovascular Diseases1
Central Nervous System Diseases1
Cognition Disorders1
Cognitive Dysfunction1
Dementia1
Heart Diseases1
Infarction1
Inflammation1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.